The granin protein family: Markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors, Journal of Endocrinological Investigation, vol.85, issue.3, pp.207-232, 1994. ,
DOI : 10.1172/JCI114604
Secretogranin II: Molecular properties, regulation of biosynthesis and processing to the neuropeptide secretoneurin, Progress in Neurobiology, vol.46, issue.1, pp.49-70, 1995. ,
DOI : 10.1016/0301-0082(94)00060-U
The chromogranins A and B: The first 25 years and future perspectives, Neuroscience, vol.49, issue.3, pp.497-528, 1992. ,
DOI : 10.1016/0306-4522(92)90222-N
Chromogranins A and B are co-localized with atrial natriuretic peptides in secretory granules of rat heart., Journal of Histochemistry & Cytochemistry, vol.38, issue.6, pp.845-50, 1990. ,
DOI : 10.1177/38.6.2139887
URL : http://journals.sagepub.com/doi/pdf/10.1177/38.6.2139887
Presence of chromogranin-derived antimicrobial peptides in plasma during coronary artery bypass surgery and evidence of an immune origin of these peptides, Blood, vol.100, issue.2, pp.553-562, 2002. ,
DOI : 10.1182/blood.V100.2.553
Expression and Localization of Chromogranin A Gene and Protein in Human Submandibular Gland, Cells Tissues Organs, vol.80, issue.4, pp.237-281, 2005. ,
DOI : 10.1016/0306-4522(92)90222-N
The Chromogranin???Secretogranin Family, New England Journal of Medicine, vol.348, issue.12, pp.1134-1183, 2003. ,
DOI : 10.1056/NEJMra021405
The granin family of uniquely acidic proteins of the diffuse neuroendocrine system: comparative and functional aspects, Biological Reviews, vol.266, issue.4, pp.769-94, 2004. ,
DOI : 10.1016/S0167-4838(97)00137-4
The Release of Protein from the Stimulated Adrenal Medulla, Biochemical Journal, vol.97, issue.3, pp.40-41, 1965. ,
DOI : 10.1042/bj0970040C
URL : http://europepmc.org/articles/pmc1264782?pdf=render
Tyrosine-O-sulfated proteins of PC12 pheochromocytoma cells and their sulfation by a tyrosylprotein sulfotransferase, J Biol Chem, vol.258, pp.11326-11360, 1983. ,
Secretogranins I and II: two tyrosine-sulfated secretory proteins common to a variety of cells secreting peptides by the regulated pathway, The Journal of Cell Biology, vol.101, issue.5, pp.1999-2011, 1985. ,
DOI : 10.1083/jcb.101.5.1999
1B1075: a brain- and pituitary-specific mRNA that encodes a novel chromogranin/secretogranin-like component of intracellular vesicles, The Journal of Neuroscience, vol.10, issue.9, pp.3135-3182, 1990. ,
DOI : 10.1523/JNEUROSCI.10-09-03135.1990
URL : http://www.jneurosci.org/content/10/9/3135.full.pdf
Monoclonal antibody HISL-19 as an immunocytochemical probe for neuroendocrine differentiation. Its application in diagnostic pathology, Am J Pathol, vol.123, pp.100-108, 1986. ,
Tissue Distribution and Molecular Forms of a Novel Pituitary Protein in the Rat, Neuroendocrinology, vol.39, issue.5, pp.453-461, 1984. ,
DOI : 10.1159/000124020
Receptor Antagonist Activity, Journal of Biological Chemistry, vol.265, issue.17, pp.11657-62, 1997. ,
DOI : 10.1093/nar/19.17.4725
Molecular cloning of a gene sequence regulated by nerve growth factor, Science, vol.229, issue.4711, pp.393-398, 1985. ,
DOI : 10.1126/science.3839317
URL : https://zenodo.org/record/1231219/files/article.pdf
Identification and Characterization of proSAAS, a Granin-Like Neuroendocrine Peptide Precursor that Inhibits Prohormone Processing, The Journal of Neuroscience, vol.20, issue.2, pp.639-687, 2000. ,
DOI : 10.1523/JNEUROSCI.20-02-00639.2000
URL : http://www.jneurosci.org/content/20/2/639.full.pdf
Milieu-induced, selective aggregation of regulated secretory proteins in the trans-Golgi network, The Journal of Cell Biology, vol.115, issue.6, pp.1505-1524, 1991. ,
DOI : 10.1083/jcb.115.6.1505
URL : https://hal.archives-ouvertes.fr/hal-01829238
Chromogranin A: current status as a precursor for bioactive peptides and a granulogenic/sorting factor in the regulated secretory pathway, Regulatory Peptides, vol.58, issue.3, pp.65-88, 1995. ,
DOI : 10.1016/0167-0115(95)00069-N
Chromogranin A, an ???On/Off??? Switch Controlling Dense-Core Secretory Granule Biogenesis, Cell, vol.106, issue.4, pp.499-509, 2001. ,
DOI : 10.1016/S0092-8674(01)00459-7
URL : https://doi.org/10.1016/s0092-8674(01)00459-7
Chromogranins A and B and secretogranin II: evolutionary and functional aspects, Acta Physiologica, vol.146, issue.2, pp.309-333, 2008. ,
DOI : 10.1111/j.1476-5381.1967.tb01980.x
New insights into granin-derived peptides: evolution and endocrine roles, General and Comparative Endocrinology, vol.164, issue.2-3, pp.161-74, 2009. ,
DOI : 10.1016/j.ygcen.2009.01.011
The biological characteristics of chromogranin A and its role as a circulating marker in neuroendocrine tumours, Anticancer Res, vol.19, pp.3415-3442, 1999. ,
Plasma Chromogranin A in Pheochromocytoma, Primary Hyperparathyroidism and Pituitary Adenoma in Comparison with Catecholamine, Parathyroid Hormone and Pituitary Hormones., Endocrine Journal, vol.44, issue.2, pp.319-346, 1997. ,
DOI : 10.1507/endocrj.44.319
Identification of Potential Gene Markers and Insights into the Pathophysiology of Pheochromocytoma Malignancy, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.12, pp.4865-72, 2007. ,
DOI : 10.1210/jc.2007-1253
The Succinate Dehydrogenase Genetic Testing in a Large Prospective Series of Patients with Paragangliomas, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.8, pp.2817-2844, 2009. ,
DOI : 10.1210/jc.2008-2504
Phaeochromocytoma, The Lancet, vol.366, issue.9486, pp.665-75, 2005. ,
DOI : 10.1016/S0140-6736(05)67139-5
Diagnostic Management of Benign and Malignant Pheochromocytoma, Experimental and Clinical Endocrinology & Diabetes, vol.115, issue.03, pp.155-164, 2007. ,
DOI : 10.1055/s-2007-970410
Chromogranin: widespread immunoreactivity in polypeptide hormone producing tissues and in serum, Regulatory Peptides, vol.6, issue.3, pp.263-80, 1983. ,
DOI : 10.1016/0167-0115(83)90145-3
Chromogranin A: Immunohistology reveals its universal occurrence in normal polypeptide hormone producing endocrine glands, Life Sciences, vol.33, issue.17, pp.1657-63, 1983. ,
DOI : 10.1016/0024-3205(83)90721-X
Immunoreactive human chromogranin A in diverse polypeptide hormone producing human tumors and normal endocrine tissues, J Clin Endocrinol Metab, vol.57, pp.1084-1090, 1983. ,
Radioimmunoassay of Chromogranin a in Plasma as a Measure of Exocytotic Sympathoadrenal Activity in Normal Subjects and Patients with Pheochromocytoma, New England Journal of Medicine, vol.311, issue.12, pp.764-70, 1984. ,
DOI : 10.1056/NEJM198409203111204
Enzyme-linked immunosorbent assay for chromogranin A, Clin Chem, vol.35, pp.1934-1942, 1989. ,
A new human chromogranin A (CgA) immunoradiometric assay involving monoclonal antibodies raised against the unprocessed central domain (145-245), British Journal of Cancer, vol.79, issue.1, pp.145-24565, 1999. ,
DOI : 10.1038/sj.bjc.6690013
URL : http://www.nature.com/bjc/journal/v79/n1/pdf/6690013a.pdf
Chromogranin A Expression in Phaeochromocytomas Associated with von Hippel-Lindau Syndrome and Multiple Endocrine Neoplasia Type 2, Hormone and Metabolic Research, vol.39, issue.12, pp.876-83, 2007. ,
DOI : 10.1055/s-2007-993135
Chromogranin A Storage and Secretion, Medicine, vol.70, issue.1, pp.33-45, 1991. ,
DOI : 10.1097/00005792-199101000-00003
Chromogranin A in familial pheochromocytoma: Diagnostic screening value, prediction of tumor mass, and post-resection kinetics indicating two-compartment distribution, The American Journal of Medicine, vol.88, issue.6, pp.607-620, 1990. ,
DOI : 10.1016/0002-9343(90)90526-J
Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones, J Clin Endocrinol Metab, vol.82, pp.2622-2630, 1997. ,
Sensitivity and specificity of a new ELISA method for determination of chromogranin A in the diagnosis of pheochromocytoma and neuroblastoma, Clinica Chimica Acta, vol.239, issue.1, pp.57-63, 1995. ,
DOI : 10.1016/0009-8981(95)06100-R
Chromogranin A and chromogranin B are sensitive circulating markers for phaeochromocytoma, European Journal of Endocrinology, vol.136, issue.1, pp.67-73, 1997. ,
DOI : 10.1530/eje.0.1360067
Serum chromogranin-alpha immunoradiometric assay in the diagnosis of pheochromocytoma, The International Journal of Biological Markers, vol.17, issue.2, pp.130-134, 2002. ,
DOI : 10.5301/JBM.2008.1853
Chromogranin A assay and (131)I-MIBG scintigraphy for diagnosis and follow-up of pheochromocytoma, J Nucl Med, vol.42, pp.993-1000, 2001. ,
An analysis of the biochemical diagnosis of 66 pheochromocytomas, European Journal of Endocrinology, vol.156, issue.5, pp.569-75, 2007. ,
DOI : 10.1530/EJE-06-0640
Chromogranin A immunoradiometric assay in diagnosis of pheochromocytoma: comparison with plasma metanephrines and 123I-MIBG scan, Q J Nucl Med Mol Imaging, vol.50, pp.344-351, 2006. ,
The role of chromogranin A in the management of patients with phaeochromocytoma, Clinical Endocrinology, vol.38, issue.3, pp.287-93, 2006. ,
DOI : 10.1210/er.2002-0013
Evolving Concepts in the Pathophysiology, Diagnosis, and Treatment of Pheochromocytoma, Endocrine Reviews, vol.15, issue.3, pp.356-68, 1994. ,
DOI : 10.1210/edrv-15-3-356
Pheochromocytoma: State-of-the-Art and Future Prospects, Endocrine Reviews, vol.24, issue.4, pp.539-53, 2003. ,
DOI : 10.1210/er.2002-0013
Plasma Chromogranin A or Urine Fractionated Metanephrines Follow-Up Testing Improves the Diagnostic Accuracy of Plasma Fractionated Metanephrines for Pheochromocytoma, The Journal of Clinical Endocrinology & Metabolism, vol.93, issue.1, pp.91-96, 2008. ,
DOI : 10.1210/jc.2007-1354
URL : https://academic.oup.com/jcem/article-pdf/93/1/91/9052389/jcem0091.pdf
Diagnostic specificity of serum chromogranin-A for pheochromocytoma in patients with renal dysfunction, J Clin Endocrinol Metab, vol.78, pp.1139-1183, 1994. ,
Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours, Journal of Endocrinology, vol.144, issue.1, pp.49-59, 1995. ,
DOI : 10.1677/joe.0.1440049
Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy, European Journal of Clinical Investigation, vol.104, issue.9 ,
DOI : 10.1210/jc.84.8.2712
, Eur J Clin Invest, vol.31, pp.802-813, 2001.
Marked chromogranin A elevation in a patient with bilateral adrenal incidentalomas, and its rapid normalization after discontinuation of proton pump inhibitor therapy, Clinical Endocrinology, vol.14, issue.5, pp.805-811, 2007. ,
DOI : 10.1046/j.1365-2036.1999.00466.x
Basal Chromogranin a and Gastrin Concentrations in Circulation Correlate to Endocrine Cell Proliferation in Type-A Gastritis, Scandinavian Journal of Gastroenterology, vol.110, issue.3, pp.198-202, 1997. ,
DOI : 10.3109/00365517209081114
Serum chromogranin-A in hepatocellular carcinoma: Diagnostic utility and limits, World Journal of Gastroenterology, vol.11, issue.13, pp.1987-90, 2005. ,
DOI : 10.1007/0-306-46837-9_28
A comparison between three commercial kits for chromogranin A measurements, Journal of Endocrinology, vol.177, issue.2, pp.337-378, 2003. ,
DOI : 10.1677/joe.0.1770337
Chromogranin A, a member of neuroendocrine secretory proteins as a selective marker for laboratory diagnosis of pheochromocytoma, Physiol Res, vol.57, pp.171-180, 2008. ,
Measurements of chromogranin B can serve as a complement to chromogranin A, Regulatory Peptides, vol.139, issue.1-3, pp.80-83, 2007. ,
DOI : 10.1016/j.regpep.2006.10.008
High plasma levels of human chromogranin A and adrenomedullin in patients with pheochromocytoma, Tumori, vol.91, pp.53-61, 2005. ,
Malignant Pheochromocytoma : Chromaffin Granule Transmitters and Response to Treatment, Hypertension, vol.36, issue.6, pp.1045-52, 2000. ,
DOI : 10.1161/01.HYP.36.6.1045
URL : https://www.ahajournals.org/doi/pdf/10.1161/01.HYP.36.6.1045
Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to Separate Benign From Malignant Neoplasms, The American Journal of Surgical Pathology, vol.26, issue.5, pp.551-66, 2002. ,
DOI : 10.1097/00000478-200205000-00002
Chromogranin A in Human Neuroendocrine Tumors, The American Journal of Surgical Pathology, vol.25, issue.10, pp.1261-1268, 2001. ,
DOI : 10.1097/00000478-200110000-00006
Isolation and primary structure of a novel chromogranin A-derived peptide, WE-14, from a human midgut carcinoid tumour, FEBS Letters, vol.288, issue.3, pp.319-340, 1992. ,
DOI : 10.1016/0014-5793(88)80606-9
Isolation of peptides arising from the specific posttranslational processing of chromogranin A and chromogranin B from human pheochromocytoma tissue, Peptides, vol.13, issue.4, pp.639-683, 1992. ,
DOI : 10.1016/0196-9781(92)90167-2
Occurrence of WE-14 and chromogranin A-derived peptides in tissues of the human and bovine gastro-entero-pancreatic system and in human neuroendocrine neoplasia, Journal of Endocrinology, vol.151, issue.3, pp.409-429, 1996. ,
DOI : 10.1677/joe.0.1510409
Localization and characterization of evolutionarily conserved chromogranin A-derived peptides in the rat and human pituitary and adrenal glands, Cell and Tissue Research, vol.310, issue.2, pp.223-259, 2002. ,
DOI : 10.1007/s00441-002-0625-9
URL : https://hal.archives-ouvertes.fr/hal-01973127
Development of Novel Tools for the Diagnosis and Prognosis of Pheochromocytoma Using Peptide Marker Immunoassay and Gene Expression Profiling Approaches, Annals of the New York Academy of Sciences, vol.20, issue.1, pp.533-573, 2006. ,
DOI : 10.1097/01.cco.0000142070.45097.68
URL : https://hal.archives-ouvertes.fr/hal-01706439
Metoclopramide stimulates catecholamine- and granin-derived peptide secretion from pheochromocytoma cells through activation of serotonin type 4 (5-HT4) receptors, Endocrine Related Cancer, vol.16, issue.1, pp.281-90, 2009. ,
DOI : 10.1677/ERC-08-0190
URL : https://hal.archives-ouvertes.fr/hal-01706408
The occurrence of pancreastatin in tumours of the diffuse neuroendocrine system, Molecular and Cellular Probes, vol.2, issue.3, pp.225-260, 1988. ,
DOI : 10.1016/0890-8508(88)90006-0
The primary structure of human secretogranin I (chromogranin B): comparison with chromogranin A reveals homologous terminal domains and a large intervening variable region, EMBO J, vol.6, pp.1203-1214, 1987. ,
Immunological studies on the distribution of chromogranin A and B in endocrine and nervous tissues, Neuroscience, vol.16, issue.3, pp.547-55, 1985. ,
DOI : 10.1016/0306-4522(85)90191-5
Chromogranin A, B, and C in human adrenal medulla and endocrine tissues, Lab Invest, vol.55, pp.405-416, 1986. ,
Distribution of chromogranin A and secretogranin I (chromogranin B) in neuroendocrine cells and tumors, Am J Pathol, vol.130, pp.296-304, 1988. ,
Immunological Studies on the Occurrence and Properties of Chromogranin A and B and Secretogranin II in Endocrine Tumors, The American Journal of Surgical Pathology, vol.12, issue.11, pp.877-84, 1988. ,
DOI : 10.1097/00000478-198811000-00008
Expression of chromogranins A, B, and C (secretogranin II) in human adrenal medulla and in benign and malignant pheochromocytomas An immunohistochemical study with region-specific antibodies, APMIS, vol.141, issue.10, pp.663-73, 2004. ,
DOI : 10.1097/00000478-200205000-00002
Gawk, a novel human pituitary polypeptide: Isolation, immunocytochemical localization and complete amino acid sequence, Biochemical and Biophysical Research Communications, vol.126, issue.1, pp.602-611, 1985. ,
DOI : 10.1016/0006-291X(85)90648-5
Chromogranin B (secretogranin I), a putative precursor of two novel pituitary peptides through processing at paired basic residues, FEBS Letters, vol.493, issue.1, pp.142-150, 1987. ,
DOI : 10.1111/j.1749-6632.1987.tb27189.x
,
, The distribution of GAWK-like immunoreactivity in neuroendocrine cells of the human gut, pancreas, adrenal and pituitary glands and its co-localisation with chromogranin B, Histochemistry, vol.90, pp.475-83, 1989.
Production of GAWK (chromogranin-B 420-493)-like immunoreactivity by endocrine tumors and its possible diagnostic value., Journal of Clinical Investigation, vol.83, issue.6, pp.1834-1876, 1989. ,
DOI : 10.1172/JCI114089
Comparison of chromogranins A, B, and secretogranin II in human adrenal medulla and pheochromocytoma, Lab Invest, vol.57, pp.385-91, 1987. ,
Expression and Processing of the Neuroendocrine Protein Secretogranin II in Benign and Malignant Pheochromocytomas, Annals of the New York Academy of Sciences, vol.5, issue.1, pp.527-559, 2006. ,
DOI : 10.1046/j.1460-9568.2003.02426.x
URL : https://hal.archives-ouvertes.fr/hal-00653225
Measurements of secretogranins II, III, V and proconvertases 1/3 and 2 in plasma from patients with neuroendocrine tumours, Regulatory Peptides, vol.148, issue.1-3, pp.95-103, 2008. ,
DOI : 10.1016/j.regpep.2008.03.007
Secretoneurin: a functional neuropeptide in health and disease, Peptides, vol.21, issue.8, pp.1289-98, 2000. ,
DOI : 10.1016/S0196-9781(00)00271-0
Secretoneurin: A New Player in Angiogenesis and Chemotaxis Linking Nerves, Blood Vessels and the Immune System, Current Protein & Peptide Science, vol.6, issue.4, pp.373-85, 2005. ,
DOI : 10.2174/1389203054546334
Secretoneurin???a neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C), Neuroscience, vol.53, issue.2, pp.359-65, 1993. ,
DOI : 10.1016/0306-4522(93)90200-Y
Immunohistochemical detection of secretoneurin, a novel neuropeptide endoproteolytically processed from secretogranin II, in normal human endocrine and neuronal tissues, The Histochemical Journal, vol.18, issue.6, pp.473-81, 1995. ,
DOI : 10.1016/0016-5085(88)90374-5
Levels and Molecular Properties of Secretoneurin-Immunoreactivity in the Serum and Urine of Control and Neuroendocrine Tumor Patients, Journal of Clinical Endocrinology & Metabolism, vol.85, issue.1, pp.355-60, 2000. ,
DOI : 10.1210/jc.85.1.355
Molecular cloning of frog secretogranin II reveals the occurrence of several highly conserved potential regulatory peptides, FEBS Letters, vol.66, issue.3, pp.295-304, 1996. ,
DOI : 10.1046/j.1471-4159.1996.66062248.x
Identification of a novel secretogranin II-derived peptide (SgII(187?252)) in adult and fetal human adrenal glands using antibodies raised against the human recombinant peptide, J Clin Endocrinol Metab, vol.83, pp.2944-51, 1998. ,
URL : https://hal.archives-ouvertes.fr/hal-01706430
Biochemical Characterization and Immunocytochemical Localization of EM66, a Novel Peptide Derived from Secretogranin II, in the Rat Pituitary and Adrenal Glands, Journal of Histochemistry & Cytochemistry, vol.60, issue.8, pp.1083-95, 2003. ,
DOI : 10.1074/jbc.275.17.12553
URL : https://hal.archives-ouvertes.fr/hal-01706425
Involvement of multiple signaling pathways in PACAP-induced EM66 secretion from chromaffin cells, Regulatory Peptides, vol.137, issue.1-2, pp.79-88, 2006. ,
DOI : 10.1016/j.regpep.2006.04.023
URL : https://hal.archives-ouvertes.fr/hal-01706412
Malignant Tumors, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.6, pp.2579-85, 2003. ,
DOI : 10.1210/jc.2002-021748
URL : https://hal.archives-ouvertes.fr/hal-01706414
Circulating EM66 is a highly sensitive marker for the diagnosis and follow-up of pheochromocytoma, International Journal of Cancer, vol.24, issue.8, pp.2003-2015, 2006. ,
DOI : 10.1001/jama.288.3.314
URL : https://hal.archives-ouvertes.fr/hal-01706431
Identification of the endocrine cells detected by the monoclonal antibody HISL-19 in human tissues, Basic Appl Histochem, vol.34, pp.259-68, 1990. ,
Immunohistochemical, Biochemical and Immunoelectron Microscopic Analysis of Antigenic Proteins on Neuroendocrine Cell Tumors Using Monoclonal Antibody HISL-19, Journal of Nippon Medical School, vol.69, issue.4, pp.365-72, 2002. ,
DOI : 10.1272/jnms.69.365
Presence of the Novel Pituitary Protein ?7B2? in Bovine Chromaffin Granules: Possible Co-Release of 7B2 and Catecholamine as Induced by Nicotine, Journal of Neurochemistry, vol.113, issue.6, pp.1810-1814, 1987. ,
DOI : 10.1042/bj1030480
Cloning, Characterization, and Sequence of a Porcine cDNA Encoding a Secreted Neuronal and Endocrine Protein, DNA, vol.7, issue.10, pp.713-722, 1988. ,
DOI : 10.1089/dna.1988.7.713
Identification and Localization of 7B2 Protein in Human, Porcine, and Rat Thyroid Gland and in Human Medullary Carcinoma*, Endocrinology, vol.123, issue.2, pp.866-73, 1988. ,
DOI : 10.1210/endo-123-2-866
Multiple peptide production and presence of general neuroendocrine markers detected in 12 cases of human phaeochromocytoma and in mammalian adrenal glands, Virchows Archiv A Pathological Anatomy and Histopathology, vol.107, issue.Suppl 2, pp.399-411, 1988. ,
DOI : 10.1210/jcem-53-1-212
Expression of the neuroendocrine cell marker 7B2 in human ACTH secreting tumours, Clinical Endocrinology, vol.58, issue.6, pp.597-603, 1992. ,
DOI : 10.1111/j.1365-2826.1991.tb00268.x
Plasma 7B2 (A Novel Pituitary Protein) Immunoreactivity Concentrations in Patients with Various Endocrine Disorders., Endocrinologia Japonica, vol.35, issue.4, pp.651-655, 1988. ,
DOI : 10.1507/endocrj1954.35.651
Neuroendocrine Secretory Protein 55, Annals of the New York Academy of Sciences, vol.110, issue.1, pp.317-339, 2002. ,
DOI : 10.1111/j.1749-6632.2002.tb04486.x
The new chromogranin-like protein NESP55 is preferentially localized in adrenaline-synthesizing cells of the bovine and rat adrenal medulla, Neuroscience Letters, vol.263, issue.1, pp.13-19, 1999. ,
DOI : 10.1016/S0304-3940(99)00091-9
NESP55, a novel chromogranin-like peptide, is expressed in endocrine tumours of the pancreas and adrenal medulla but not in ileal carcinoids, British Journal of Cancer, vol.49, issue.11, pp.1746-54, 2003. ,
DOI : 10.1016/0306-4522(92)90222-N
Importance of Vesicle Proteins in the Diagnosis and Treatment of Neuroendocrine Tumors, Annals of the New York Academy of Sciences, vol.733, issue.1, pp.280-283, 2004. ,
DOI : 10.1111/j.1749-6632.1994.tb17299.x
Neuroendocrine Secretory Protein-55 (NESP-55) Expression Discriminates Pancreatic Endocrine Tumors and Pheochromocytomas From Gastrointestinal and Pulmonary Carcinoids, The American Journal of Surgical Pathology, vol.28, issue.10, pp.1371-1379, 2004. ,
DOI : 10.1097/01.pas.0000135527.96318.20
Processing of proSAAS in neuroendocrine cell lines, Biochemical Journal, vol.361, issue.1, pp.67-76, 2002. ,
DOI : 10.1042/bj3610067
Quantification of VGF- and pro-SAAS-derived peptides in endocrine tissues and the brain, and their regulation by diet and cold stress, Brain Research, vol.1089, issue.1, pp.21-32, 2006. ,
DOI : 10.1016/j.brainres.2006.02.124
Are Produced in Human Neuroendocrine Cells from Early Development and Increase in Hyperplasia and Neoplasia, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.7, pp.2811-2816, 2007. ,
DOI : 10.1210/jc.2007-0035
Distribution of PROSAAS-derived peptides in rat neuroendocrine tissues, Neuroscience, vol.105, issue.2, pp.469-78, 2001. ,
DOI : 10.1016/S0306-4522(01)00200-7
Molecular and cellular biology of pheochromocytomas and extra-adrenal paragangliomas, Endocrine Pathology, vol.303, issue.4, pp.321-329, 2006. ,
DOI : 10.1007/s12022-006-0003-3
An assessment of biochemical tests for the diagnosis of pheochromocytoma, Nature Clinical Practice Endocrinology & Metabolism, vol.156, issue.11, pp.744-749, 2007. ,
DOI : 10.7326/0003-4819-123-2-199507150-00004
Development and validation of pheochromocytoma of the adrenal gland scaled score for predicting malignant pheochromocytomas, Urology, vol.68, issue.2, pp.282-288, 2006. ,
DOI : 10.1016/j.urology.2006.02.019
Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis, Surgery, vol.143, issue.6, pp.759-68, 2008. ,
DOI : 10.1016/j.surg.2008.02.007
Gene Expression Profiling of Benign and Malignant Pheochromocytoma, Annals of the New York Academy of Sciences, vol.32, issue.1, pp.541-56, 2006. ,
DOI : 10.1530/eje.0.1470085
Biochemical and Clinical Manifestations of Dopamine-Producing Paragangliomas: Utility of Plasma Methoxytyramine, The Journal of Clinical Endocrinology & Metabolism, vol.90, issue.4, pp.2068-75, 2005. ,
DOI : 10.1210/jc.2004-2025
URL : https://academic.oup.com/jcem/article-pdf/90/4/2068/10775392/jcem2068.pdf
Genetic markers for the diagnosis and prognosis of pheochromocytoma, Expert Review of Endocrinology & Metabolism, vol.103, issue.1, pp.45-52, 2009. ,
DOI : 10.1007/BF01938677
Imaging vs Biochemical Testing for Pheochromocytoma, JAMA: The Journal of the American Medical Association, vol.288, issue.3, pp.314-319, 2002. ,
DOI : 10.1001/jama.288.3.314
The Economic Implications of Three Biochemical Screening Algorithms for Pheochromocytoma, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.6, pp.2859-66, 2004. ,
DOI : 10.1210/jc.2003-031127
Pheochromocytoma and extra-adrenal paraganglioma, Updates Arch Pathol Lab Med, vol.132, pp.1272-84, 2008. ,
Histological Grading of Adrenal and Extra-adrenal Pheochromocytomas and Relationship to Prognosis: A Clinicopathological Analysis of 116 Adrenal Pheochromocytomas and 30 Extra-adrenal Sympathetic Paragangliomas Including 38 Malignant Tumors, Endocrine Pathology, vol.16, issue.1, pp.23-32, 2005. ,
DOI : 10.1385/EP:16:1:023
Chromogranin A, a member of neuroendocrine secretory proteins as a selective marker for laboratory diagnosis of pheochromocytoma, Physiol Res, vol.57, pp.171-180, 2008. ,
Chromogranin A expression in neoplastic cells affects tumor growth and morphogenesis in mouse models, Cancer Res, vol.62, pp.941-947, 2002. ,